4.6 Review

Menstrual cycle-related exacerbation of disease

Journal

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 202, Issue 3, Pages 221-231

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2009.07.061

Keywords

exacerbation; major depressive disorder; menstrual cycle; premenstrual dysphoric disorder; transition to menopause

Funding

  1. Wyeth Research, Collegeville, PA
  2. Wyeth
  3. Solvay
  4. Lilly
  5. Pfizer
  6. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036887, U54HD052668] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Exacerbation of common medical and mental health disorders at specific phases of the menstrual cycle is a prevalent phenomenon. Although the precise cause is unclear, studies implicate complex interactions between the immune and neuroendocrine systems. The menstrual cycle also is a trigger for the onset of depressive disorders, including premenstrual dysphoric disorder, a disorder specific to the luteal phase of the menstrual cycle, and depression associated with the transition to menopause. This article discusses common mental health problems exacerbated by the menstrual cycle, with a particular focus on premenstrual dysphoric disorder and perimenopausal depression. Throughout the reproductive lifespan, routine screening and assessment for the presence of common psychiatric disorders are critical for accurate diagnosis and provision of effective treatment. Management options include referral or consultation with a primary care provider or psychiatrist; treatment options for premenstrual dysphoric disorder and perimenopausal depression include pharmacotherapy with antidepressant agents and/or psychotherapy. Hormones may be helpful.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available